Skip to main content
SpringerLink
Log in

Esophageal hypomotility in systemie sclerosis: Close relationship with pulmonary involvement

  • Original Articles
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Purpose: Esophageal motility was assessed in patients with systemic selerosis (SSc) by scintigraphy and compared with (i) extent of scleroderma, (ii) duration of disease, (iii) index of antitopoisomerase I antibody (topo I), and (iv) pulmonary involvement.Methods: A multiple-swallow test was performed in 47 patients with SSc in the supine position with99mTc-DTPA. A region of interest on the entire esophagus was defined and the retention ratio (RR) was calculated from a time-activity curve.Results: Patients with diffuse scleroderma had higher RRs than those with limited scleroderma (48.8% vs. 30.0%; p<0.05). There was no correlation between the RRs and the duration of disease. Patients with positive topo I had higher RRs than those who were negative (53.8% vs. 29.7%; p<0.05). Patients with reduced % diffusion capacity for carbon monoxide (%DLCO) had higher RRs thans those with normal %DLCO (40.5% vs. 19.6%; p=0.03). Patients with reduced % vital capacity (%VC) had higher RRs than those with normal % VC (54.6% vs. 25.0%; p<0.005). Patients with pulmonary fibrosis had higher RRs than those who were negative (58.5% vs. 20.3%; p<0.00005).Conclusion: Esophageal dysfunction in patients with SSc showed a correlation with the extent of scleroderma, positive topo I, and pulmonary involvement. The RR can be an objective clinical marker for the severity of organ fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (Systemic Sclerosis). Classification, Subsets and Pathogenesis.J Rheumatol 1988; 15: 202–205.

    PubMed  CAS  Google Scholar 

  2. Cohen S. The gastrointestinal manifestations of scleroderma: Pathogenesis and management.Gastroenterology 1980; 79: 155–166.

    PubMed  CAS  Google Scholar 

  3. D’Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls.Am J Med 1969; 46: 428–440.

    Article  PubMed  CAS  Google Scholar 

  4. Taillefer R, Jadliwalla M, Pellerin E, Lafontaine E, Duranceau, A. Radionuclide esophageal transit study in detection of esophageal motor dysfunction: Comparison with motility studies (Manometry).J Nucl Med 1990; 31: 1921–1926.

    PubMed  CAS  Google Scholar 

  5. Drane WE, Karvelis K, Johnson DA Curran JJ, Silverman ED. Progressive systemic sclerosis: Radionuclide esophageal scintigraphy and manometry.Radiology 1986; 160: 73–76.

    PubMed  CAS  Google Scholar 

  6. Drane WE, Karvelis K, Johnson DA, Curran JJ, Silverman ED. Scintigraphic detection of metoclopramide esophageal stimulation in progressive systemic sclerosis.J Nucl Med 1987; 28: 810–815.

    PubMed  CAS  Google Scholar 

  7. Limburg AJ, Beekhuis H, Smit AJ. Esophageal hypomotility in primary and secondary Raynaud’s phenomenon: Comparison of esophageal scintigraphy with manometry.J Nucl Med 1995; 36: 451–455.

    PubMed  CAS  Google Scholar 

  8. Russell COH, Hill LD, Holmes ER. Radionuclide transit: A sensitive screening test for esophageal dysfunction.Gastroenterology 1981; 80: 887–892.

    PubMed  CAS  Google Scholar 

  9. Blackwell JN, Hannan WJ, Adam RD, Heading RC. Radionuclide transit studies in the detection of esophageal dysfunction.Gut 1983; 24: 421–426.

    Article  PubMed  CAS  Google Scholar 

  10. Carette S, Lacourciere Y, Lavoie S, Halle P. Radionuclide esophageal transit in progressive systemic sclerosis.J Rheumatol 1985; 12: 478–481.

    PubMed  CAS  Google Scholar 

  11. Barnett AJ. Scleroderma (Progressive systemic sclerosis): Prognosis and course based on a personal series of 118 cases.Med J Aust 1978; 2: 129–134.

    PubMed  CAS  Google Scholar 

  12. Steen VD, Powell DL, Medsger TA. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.Arthritis Rheum 1988; 31: 196–203.

    Article  PubMed  CAS  Google Scholar 

  13. Catoggio LJ, Bernstein RM, Black CM, Hughs GRV, Maddison PJ. Serological markers in progressive systemic sclerosis: clinical correlations.Ann Sheum Dis 1983; 42: 23–27.

    Article  CAS  Google Scholar 

  14. Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.J Rheumatol 1986; 13: 911–916.

    PubMed  CAS  Google Scholar 

  15. Shero JH, Bordwell B, Rothfield NF, Earnshaw WC. High titers of autoantibodies to topoisomerase I (Scl70) in sera from scleroderma patients.Science 1986; 231: 737–740.

    Article  PubMed  CAS  Google Scholar 

  16. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantigenic epitopes on DNA topoisomerase I.Arthritis Rheum 1993; 36: 1406–1413.

    Article  PubMed  CAS  Google Scholar 

  17. Briggs DC, Vaughn RW, Welsh KI, Myers A, DuBois RM, Black CM. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis.Lancet 1991; 338: 661–662.

    Article  PubMed  CAS  Google Scholar 

  18. Greenwald GI, Tashkin DP, Gong H, Duann MSS. Longitudinal change in lung function and respiratory symptoms in progressive systemic sclerosis.Am J Med 1987; 83: 83–92.

    Article  PubMed  CAS  Google Scholar 

  19. Black CM, Du Bois RM. Organ involvement: Pulmonary. InSystemic Sclerosis, Clements, PJ, Furst DE (ed), 1st ed, Baltimore; Williams and Wilkins, Inc., 1996: 299–331.

    Google Scholar 

  20. Colp CR, Riker J, Williams MH. Serial changes in scleroderma and idiopathic interstitial lung disease.Arch Intern Med 1973; 132: 506–515.

    Article  PubMed  CAS  Google Scholar 

  21. Bagg LR, Hughes DTD. Serial pulmonary function tests in progressive systemic sclerosis.Thorax 1979; 34: 224–228.

    PubMed  CAS  Google Scholar 

  22. Schneider PD, Wise RA, Hochberg MC, Wigley FM. Serial pulmonary function in systemic sclerosis.Am J Med 1982; 73: 385–394.

    Article  PubMed  CAS  Google Scholar 

  23. Hughes DTD, Lee FI. Lung function in patients with systemic sclerosis.Thorax 1963; 18: 16–20.

    Article  PubMed  CAS  Google Scholar 

  24. Murray JF. Respiratory disease. InCecil Text Book of Medicine, Wyngraarden JB, Smith LH, Benett JC (ed), 19th ed, Philadelphia; W. B. Sanders, Inc., 1992: 369–381.

    Google Scholar 

  25. Klein HA, Wald A. Normal variation in radionuclide esophageal transit studies.Eur J Nucl Med 1987; 13: 115–120.

    Article  PubMed  CAS  Google Scholar 

  26. Bartlett RJV, Parkin A, Ware FW, Riley A, Robinson PJA. Reproducibility of esophageal transit studies: several single swallows must be performed.Nucl Med Commun 1987; 8: 317–326.

    Article  PubMed  CAS  Google Scholar 

  27. Tatsch K, Schroettle W, Kirsch C-M. Multiple swallow test for the quantitative and qualitative evaluation of esophageal motility disorders.J Nucl Med 1991; 32: 1365–1370.

    PubMed  CAS  Google Scholar 

  28. Klein HA. Esophageal transit scintigraphy.Semin Nucl Med 1995; 25: 306–317.

    Article  PubMed  CAS  Google Scholar 

  29. Davidson A, Russell C, Littlejohn GO. Assessment of esophageal abnormalities in progressive systemic sclerosis using radionuclide transit.J Rheumatol 1985; 12: 472–477.

    PubMed  CAS  Google Scholar 

  30. Åkesson A, Gustafson T, Wollheim F, Brismar J. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis.Scand J Rheumatol 1987; 16: 291–299.

    Article  PubMed  Google Scholar 

  31. Baron M, Arzoumanian A. Radionuclide esophageal transit studies in progressive systemic sclerosis: An analysis of longitudinal data.J Rheumatol 1991; 18: 1837–1840.

    PubMed  CAS  Google Scholar 

  32. Denis P, Ducrotte P, Pasquis P, Lefrancois R. Esophageal motility and pulmonary function in progressive systemic sclerosis.Respiration 1981; 42: 21–24.

    PubMed  CAS  Google Scholar 

  33. Johnson DA, Drane WE, Curran J, Cattau EL, Ciarleglio C, Khan A, et al. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?.Arch Intern Med 1989; 149: 589–593.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Tonami General Hospital, 1-61 Shintomi-cho, 939-1395, Tonami, Toyama, Japan

    Keiko Kinuya

  2. Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Japan

    Kenichi Nakajima, Seigo Kinuya, Takatoshi Michigishi & Norihisa Tonami

  3. Department of Dermatology, Kanazawa University Hospital, Kanazawa, Japan

    Kazuhiko Takehara

Authors
  1. Keiko Kinuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenichi Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seigo Kinuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takatoshi Michigishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norihisa Tonami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuhiko Takehara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keiko Kinuya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinuya, K., Nakajima, K., Kinuya, S. et al. Esophageal hypomotility in systemie sclerosis: Close relationship with pulmonary involvement. Ann Nucl Med 15, 97–101 (2001). https://doi.org/10.1007/BF02988598

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02988598

Key words

Search

Navigation